Quantitative Systematic Strategies’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-159
Closed -$202K 76
2021
Q2
$202K Sell
159
-104
-40% -$117K 0.07% 424
2021
Q1
$288K Buy
+263
New +$347K 0.04% 478

Other funds holding CDLX

Quantitative Systematic Strategies's CDLX Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Cardlytics (CDLX) in Q3 2021, closing a stake of 159 shares — an estimated $202K sold.

Quantitative Systematic Strategies first reported a position in CDLX in Q1 2021 and held it in 2 quarters. The position peaked at $288K in Q1 2021. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining Cardlytics position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 159 Cardlytics shares in Q3 2021, an estimated $202K.
  • Quantitative Systematic Strategies first reported a position in Cardlytics in Q1 2021 and held it in 2 quarters.
  • Quantitative Systematic Strategies's Cardlytics position peaked at $288K in Q1 2021.
  • 164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.